Bristol Myers Squibb
The latest news about Bristol Myers Squibb: headlines, AI summaries and the full story from every source.
- Bristol Myers Squibb vs. Novo Nordisk: A Comparative Analysis of Healthcare Stocks for 2026
- Morgan Stanley Maintains Underweight Rating on Bristol Myers Squibb Despite Strong Q2 Results
- AstraZeneca Considering $400 Billion Merger with Bristol Myers Squibb
- Bristol Myers Squibb Reports Strong First-Quarter Sales Growth, Primarily from Legacy Products